Dexamethasone Treatment Options

A collection of 1455 research studies where Dexamethasone is the interventional treatment. These studies are located in the United States. Dexamethasone is used for conditions such as Multiple Myeloma, Lymphoma and Postoperative Pain.

Home

All Treatments

Dexamethasone

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

* Compensation for time may be available

Featured Trial

Chronic Cough Research Study

Recruiting

Are you tired of living with chronic cough? Our research study is now looking to enroll people from all backgrounds to help research potential new treatment options for chronic cough.
You are under no obligation to take part and health insurance is not required. Find out more today! We’d love to hear from you!

Conditions:

Chronic Cough

Refractory or Unexplained Chronic Cough

Cough

Asthma

Sinusitis

Learn More

Featured Offer

Lose Weight with GLP-1 Medications

Recruiting

Policy Lab has partnered with CareGLP to offer trusted access to GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.

GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.

As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.

Conditions:

Overweight

Overweight and Obesity

Obesity

Weight Loss

Morbid Obesity

Learn More

Featured Trial

Depressive disorder Clinical Study

Recruiting

A clinical study for people that suffer with Depressive disorder

Conditions:

Depressive disorder

Learn More

Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

NCT03860844

Terminated

Primary Objective: Evaluate the anti-leukemic activity of isatuximab in combination with standard chemotherapies in pediatric participants of ages 28 days to less than 18 years with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Acute Myeloid Leukemia (AML) Secondary Objectives: * Safety and tolerability assessments * Assessment of infusion reactions (IRs) * Pharmacokinetics (PK) of isatuximab * Minimal residual disease * Overall response rate * Overall survival * Event free surviv... Read More

Gender:

ALL

Ages:

Between 28 days and 17 years

Trial Updated:

04/22/2024

Locations: Sarah Cannon Research Institute-Site Number:8400001, Nashville, Tennessee +40 locations

Sarah Cannon Research Institute-Site Number:8400001, Nashville, Tennessee

Children's Medical Center of Dallas-Site Number:8400002, Dallas, Texas

Investigational Site Number :0320002, Caba, Buenos Aires

Investigational Site Number :0320006, Capital Federal, Buenos Aires

Investigational Site Number :0320005, Buenos Aires, Not set

Investigational Site Number :0320004, Buenos Aires, Not set

Investigational Site Number :0760013, Curitiba, Paraná

Investigational Site Number :0760006, Curitiba, Paraná

Investigational Site Number :0760007, Porto Alegre, Rio Grande Do Sul

Investigational Site Number :0760010, Jau, São Paulo

Investigational Site Number :0760009, Ribeirao Preto, São Paulo

Investigational Site Number :0760001, Sao Paulo, São Paulo

Investigational Site Number :0760004, Sao Paulo, São Paulo

Investigational Site Number :2080001, Copenhagen, Not set

Investigational Site Number :2500002, Lille, Not set

Investigational Site Number :2500003, Lyon, Not set

Investigational Site Number :2500001, PARIS Cedex 12, Not set

Investigational Site Number :2500004, PARIS Cedex 19, Not set

Investigational Site Number :2760005, Erlangen, Not set

Investigational Site Number :2760003, Hamburg, Not set

Investigational Site Number :2760006, Münster, Not set

Investigational Site Number :3000001, Athens, Not set

Investigational Site Number :3480002, Budapest, Not set

Investigational Site Number :3800002, Genova, Liguria

Investigational Site Number :3800001, Monza, Lombardia

Investigational Site Number :3800003, Torino, Piemonte

Investigational Site Number :3800005, Verona, Veneto

Investigational Site Number :4100001, Seoul, Seoul-teukbyeolsi

Investigational Site Number :4100002, Seoul, Seoul-teukbyeolsi

Investigational Site Number :4100004, Seoul, Seoul-teukbyeolsi

Investigational Site Number :4840001, Monterrey, Nuevo León

Investigational Site Number :4840005, Col. Rancho Menchaca, Querétaro

Investigational Site Number :5280001, Utrecht, Not set

Investigational Site Number :5780001, Bergen, Not set

Investigational Site Number :5780002, Oslo, Not set

Investigational Site Number :6040001, Arequipa, Not set

Investigational Site Number :6040002, Lima, Not set

Investigational Site Number :6200002, Coimbra, Not set

Investigational Site Number :6200001, Lisboa, Not set

Investigational Site Number :6200003, Porto, Not set

Investigational Site Number :7520001, Göteborg, Not set

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia

Learn More ›

Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

NCT01659658

Terminated

The purpose of this study is to provide continued access of ixazomib and/or other study medications and to continue collecting relevant safety data to monitor participant's safety, determine whether dexamethasone plus IXAZOMIB improves hematologic response, 2-year vital organ (that is, heart or kidney) deterioration and mortality rate versus a physician's choice of a chemotherapy regimen in participants diagnosed with relapsed or refractory systemic light chain (AL) amyloidosis.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/19/2024

Locations: Cedars Sinai Medical Center, Los Angeles, California +65 locations

Cedars Sinai Medical Center, Los Angeles, California

University of Chicago, Chicago, Illinois

Indiana University School of Medicine, Indianapolis, Indiana

Tufts Medical Center, Boston, Massachusetts

Boston Medical Center, Boston, Massachusetts

Karmanos Cancer Institute, Detroit, Michigan

Mayo Clinic, Rochester, Minnesota

Washington University, Saint Louis, Missouri

Columbia University Medical Center, New York, New York

Memorial Sloan Kettering Cancer Center, New York, New York

University of Cincinnati, Cincinnati, Ohio

Cleveland Clinic, Cleveland, Ohio

Vanderbilt University Medical Center, Nashville, Tennessee

University of Texas Southwestern Medical Center, Dallas, Texas

Froedtert and The Medical College of Wisconsin, Milwaukee, Wisconsin

Westmead Hospital, Westmead, New South Wales

Princess Alexandra Hospital, Woolloongabba, Queensland

Box Hill Hospital, Box Hill, Victoria

Sir Charles Gairdner Hospital, Nedlands, Western Australia

Centro de Pesquisas Oncologicas, Florianopolis, Santa Catarina

Hospital Universitario Clementino Fraga Filho (UFRJ), Rio de Janeiro, Not set

Irmandade Da Santa Casa de Misericordia de Sao Paulo, Sao Paulo, Not set

Hospital Israelita Albert Einstein, Sao Paulo, Not set

Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Not set

Tom Baker Cancer Centre, Calgary, Alberta

Cross Cancer Institute, Edmonton, Alberta

Vancouver General Hospital, Vancouver, British Columbia

Princess Margaret Hospital, Toronto, Ontario

Fakultni nemocnice Ostrava, Ostrava, Moravskoslezsk Kraj

Vseobecna fakultni nemocnice v Praze, Praha, Praha, Hlavni Mesto

Arhus Universitetshospital Arhus Sygehus, Aahus, Not set

Rigshospitalet, Copenhagen, Not set

Hotel Dieu, Nantes, Loire-Atlantique

Hopital Claude Huriez, Lille, Not set

Centre Hospitalier et Universitaire de Limoges, Limoges, Not set

Hopital Saint Louis, Paris, Not set

Hopital de Rangueil, Toulouse, Not set

Charite - Universitatsmedizin Berlin, Berlin, Not set

Universitatsklinikum Hamburg Eppendorf, Hamburg, Not set

Universitat Heidelberg, Heidelberg, Not set

University General Hospital of Patras, Patras, Achaia

Alexandra Hospital, Athens, Not set

Rambam Health Corporation, Haifa, Not set

Hadasit Medical Research Services and Development Ltd, Jerusalem, Not set

Meir Medical Center, Kfar Saba, Not set

Rabin Medical Center - PPDS, Petach Tikva, Not set

Chaim Sheba Medical Center, Ramat-Gan, Not set

Institute of Hematology "Seragnoli" University of Bologna, Bologna, Not set

Fondazione IRCCS Policlinico San Matteo di Pavia, Pavia, Not set

Gachon University Gil Medical Center, Incheon, Not set

Seoul National University Hospital, Seoul, Not set

Severance Hospital at Yonsei University Health System - PPDS, Seoul, Not set

Samsung Medical Center - PPDS, Seoul, Not set

The Catholic University of Korea, Seoul St Mary's Hospital, Seoul, Not set

VU Medisch Centrum, Amsterdam, Noord-Holland

Maastricht University Medical Center, AZ Maastricht, Not set

Universitair Medisch Centrum Utrecht, Utrecht, Not set

Clinica Universidad de Navarra, Pamplona, Navarra

Hospital Clinic de Barcelona, Barcelona, Not set

Hospital Universitario de La Princesa, Madrid, Not set

Hospital Universitario Puerta de Hierro - Majadahonda, Majadahonda, Not set

Hospital Universitario de Salamanca, Salamanca, Not set

Queen Elizabeth Hospital, Birmingham, Not set

Royal Free and University College Medical School, London, Not set

Manchester Royal Infirmary, Manchester, Not set

Oxford University Hospitals NHS Trust, Oxford, Not set

Conditions: Relapsed or Refractory Systemic Light Chain Amyloidosis

Learn More ›

Steroids After Spine Fusion Surgery

NCT04568837

Not Yet Recruiting

This trial studies how well low-dose postoperative corticosteroids (FDA approved) affect patient outcomes (patient reported outcomes, pain medication use, length of stay, major complications, and time to first bowel movement) after thoracic and/or lumbar spine fusion surgery.

Gender:

ALL

Ages:

50 years and above

Trial Updated:

04/18/2024

Locations: Oregon Health and Science University, Portland, Oregon

Conditions: Spine Fusion

Learn More ›

Sotatercept (ACE-011) With Lenalidomide or Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma

NCT01562405

Active Not Recruiting

It is possible that the combination of lenalidomide, dexamethasone and ACE 011 may reduce or prevent the growth of cancer cells along with improving anemia and bone lesions that sometimes occur in people with multiple myeloma. This current study is the first study combining ACE 011 with lenalidomide. In this research study, the investigators are looking for the highest dose of ACE 011 that can be given with lenalidomide and dexamethasone. The investigators will also begin to collect information... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/17/2024

Locations: Emory University, Atlanta, Georgia +3 locations

Conditions: Multiple Myeloma

Learn More ›

A Study in Adults With Untreated Acute Lymphoblastic Leukemia

NCT00136435

Active Not Recruiting

The purpose of this study is to determine the safety and optimal dosing of L-asparaginase in adult patients with acute lymphoblastic leukemia (ALL) between the ages of 18 and 50 years.

Gender:

ALL

Ages:

Between 18 years and 50 years

Trial Updated:

04/16/2024

Locations: Dana-Farber Cancer Institute, Boston, Massachusetts +11 locations

Conditions: Acute Lymphoblastic Leukemia

Learn More ›

Study of Venetoclax in Combination With Carfilzomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma (MM)

NCT02899052

Active Not Recruiting

A Phase 2, open-label, dose escalation study to evaluate the safety and efficacy of venetoclax in combination with carfilzomib-dexamethasone (Kd) in participants with relapsed or refractory MM and have received 1 to 3 prior lines of therapy. Part 4 of this study is currently enrolling.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/15/2024

Locations: University of Alabama at Birmingham - Main /ID# 151405, Birmingham, Alabama +31 locations

University of Alabama at Birmingham - Main /ID# 151405, Birmingham, Alabama

University of Arkansas for Medical Sciences /ID# 151399, Little Rock, Arkansas

Memorial Healthcare System /ID# 224862, Hollywood, Florida

Emory University, Winship Cancer Institute /ID# 161710, Atlanta, Georgia

The University of Chicago Medical Center /ID# 151395, Chicago, Illinois

Indiana Blood & Marrow Transpl /ID# 218862, Indianapolis, Indiana

University of Kentucky Chandler Medical Center /ID# 151407, Lexington, Kentucky

Central Maine Medical Center /ID# 218856, Lewiston, Maine

University of Maryland School of Medicine /ID# 159721, Baltimore, Maryland

Washington University-School of Medicine /ID# 222651, Saint Louis, Missouri

Oncology Hematology Associates (OHA) - Springfield /ID# 218855, Springfield, Missouri

Duke Cancer Center /ID# 162062, Durham, North Carolina

University of Pennsylvania /ID# 151768, Philadelphia, Pennsylvania

University of Texas Southwestern Medical Center /ID# 218336, Dallas, Texas

Baylor Scott & White Medical Center- Temple /ID# 218252, Temple, Texas

University of Utah /ID# 151397, Salt Lake City, Utah

Duplicate_VA Puget Sound Healthcare Syst /ID# 155369, Seattle, Washington

Aurora Health Care, Aurora Cancer Center /ID# 209612, Wauwatosa, Wisconsin

Border Medical Oncology Research Unit Albury Wodonga Regiona /ID# 222200, East Albury, New South Wales

Calvary Mater Newcastle /ID# 218739, Waratah, New South Wales

Flinders Medical Centre /ID# 221345, Bedford, Park, South Australia

Royal Hobart Hospital /ID# 217546, Hobart, Tasmania

Debreceni Egyetem-Klinikai Kozpont /ID# 217624, Debrecen, Hajdu-Bihar

Semmelweis Egyetem /ID# 217626, Budapest, Not set

Del-pesti Centrumkorhaz Orszagos Hematologiai es Infektologiai Intezet /ID# 217625, Budapest, Not set

Szegedi Tudományegyetem /ID# 219172, Szeged, Not set

Auxilio Mutuo Cancer Center /ID# 157853, San Juan, Not set

VA Caribbean Healthcare System /ID# 157854, San Juan, Not set

Hospital Universitario Germans Trias i Pujol /ID# 218006, Badalona, Barcelona

Hospital Clinic de Barcelona /ID# 218007, Barcelona, Not set

Hospital General Universitario Gregorio Maranon /ID# 218005, Madrid, Not set

Hospital Universitario Ramon y Cajal /ID# 220925, Madrid, Not set

Conditions: Multiple Myeloma

Learn More ›

A Study of Elotuzumab With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed Multiple Myeloma

NCT02718833

Active Not Recruiting

This research study is studying a combination of study drugs as a possible treatment for relapsed and refractory Multiple Myeloma. The interventions involved in this study are elotuzumab, pomalidomide, bortezomib, dexamethasone.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/14/2024

Locations: Massachusetts General Hospital Cancer Center, Boston, Massachusetts +5 locations

Conditions: Multiple Myeloma

Learn More ›

Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM

NCT04176718

Recruiting

This research study is studying the combination of daratumumab with weekly carfilzomib, pomalidomide, and dexamethasone in people with relapsed and refractory multiple myeloma. Relapsed and Refractory Multiple Myeloma is the condition of returned or previous treatment resistant Multiple Myeloma. This research study involves two study drugs and two standard of care drugs. * The names of the study drugs involved in this study are: * Carfilzomib * Daratumumab * The names of the standard of c... Read More

Gender:

ALL

Ages:

Between 18 years and 80 years

Trial Updated:

04/14/2024

Locations: Massachusetts General Hospital, Boston, Massachusetts +2 locations

Conditions: Multiple Myeloma, Refractory Multiple Myeloma, Multiple Myeloma in Relapse, Relapse

Learn More ›

A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract

NCT04539548

Completed

To assess the safety of Dextenza compared to an active control, prednisolone acetate suspension, for the treatment of postoperative pain and inflammation following ocular surgery for pediatric cataract.

Gender:

ALL

Ages:

Between 0 years and 5 years

Trial Updated:

04/11/2024

Locations: Ocular Therapeutix, Aurora, Colorado +13 locations

Conditions: Cataract

Learn More ›

Comparison of Analgesic Efficacy Between of Interscalene Block With Liposomal Bupivacaine With Bupivacaine and Dexamethasone

NCT03969875

Completed

Pain management after shoulder surgeries poses a unique challenge to the surgeon as well as the anesthesiologist. Regional anesthesia in the form of interscalene approach to the brachial plexus as an adjunct to general anesthesia or as a sole primary technique comes to one's rescue. Interscalene block either as single shot or as a catheter is an established modality for effective analgesia which facilitates early mobilization helping in physical therapy and early discharge. With the help of local anesthetic injected as a single shot, analgesia usually lasts less than 24 hours. Recent research in regional anesthesia is advancing towards adjuvants which will prolong the duration of local anesthesia. This has introduced the concept of "multimodal perineural analgesia (MMPNA)" whereby multiple agents with differing mechanisms of action are used with the goal of providing perineural analgesia while avoiding exposure to high and potentially toxic levels of individual agents. Some of the commonly used adjuvants in clinical studies are fentanyl, buprenorphine, morphine, tramadol, magnesium, epinephrine, ketamine, non-steroidal anti-inflammatory drug (NSAID), midazolam, parecoxib, ketorolac, clonidine, dexmedetomidine, dexamethasone, neostigmine and potassium. They find a distinct place in wide spread clinical practice as an off-label use. Steroids have a long history of safe use in epidural space for treatment of radicular pain due to nerve irritation. Dexamethasone is used routinely as a part of anti- emetic prophylaxis and anti-inflammatory effect. Methyl prednisone was the first steroid to be used as an adjuvant. Dexamethasone was first used as an adjuvant in 2003. It has been hypothesized that steroids induce a degree of vasoconstriction, thereby reducing local anesthetic absorption, tend to have an opioid sparing effect. Another theory suggests that it increases the activity of inhibitory potassium channels on nociceptive C-fibers (via glucocorticoid receptors), thus decreasing their activity. Several studies have demonstrated promising results with the use of 8mg of perineural dexamethasone. No neuronal injury has been reported in in vivo studies. Though there are several studies which report usage of dexamethasone in varying doses of 2mg to 8mg, the optimal effective dose of dexamethasone as an adjuvant for nerve block remains unknown. Some studies have suggested perineural is more effective than IV as an adjuvant . Liposomal bupivacaine, a formulation where bupivacaine is encapsulated into multivesicular liposomes, making it a slow and controlled release from the liposomes, was originally indicated for wound infiltration at the surgical site to provide post-surgical analgesia. Studies have demonstrated efficacy up to 24 hours in femoral nerve block in total knee arthroplasty. Recent approval of liposomal bupivacaine in interscalene block for shoulder surgeries by FDA opens an arena unexplored in the world of regional anesthesia. Current opioid epidemic, a crisis in health care forces healthcare providers to consider alternate analgesic modalities without compromising patient comfort. Regional anesthesia has revolutionized peri-operative pain management by avoiding opioids and their side effects. Use of adjuvants to the current regional techniques holds promise in postsurgical analgesia. The researchers propose to compare the analgesic efficacy of liposomal bupivacaine to bupivacaine with dexamethasone as an adjuvant in interscalene block with catheters for shoulder surgeries. Till date, there is not a single study comparing the three in current literature. Read Less

Gender:

ALL

Ages:

Between 18 years and 80 years

Trial Updated:

04/10/2024

Locations: Icahn School of Medicine at Mount Sinai, New York, New York

Conditions: Total Shoulder Arthroplasty, Shoulder Osteoarthritis

Learn More ›

One Year Trial Evaluating Safety of Ozurdex With Eylea

NCT03984110

Completed

One Year Trial Evaluating Safety of Ozurdex With Eylea (COED)

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/08/2024

Locations: Texas Retina Associates, Dallas, Texas

Conditions: Diabetic Macular Edema

Learn More ›

Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma

NCT01979536

Completed

This partially randomized phase II trial studies how well brentuximab vedotin or crizotinib and combination chemotherapy works in treating patients with newly diagnosed stage II-IV anaplastic large cell lymphoma. Brentuximab vedotin is a monoclonal antibody, called brentuximab, linked to a toxic agent called vedotin. Brentuximab attaches to CD30 positive cancer cells in targeted way and delivers vedotin to kill them. Crizotinib and methotrexate may stop the growth of cancer cells by blocking som... Read More

Gender:

ALL

Ages:

21 years and below

Trial Updated:

04/04/2024

Locations: Children's Hospital of Alabama, Birmingham, Alabama +153 locations

Children's Hospital of Alabama, Birmingham, Alabama

Phoenix Childrens Hospital, Phoenix, Arizona

Arkansas Children's Hospital, Little Rock, Arkansas

Kaiser Permanente Downey Medical Center, Downey, California

City of Hope Comprehensive Cancer Center, Duarte, California

Loma Linda University Medical Center, Loma Linda, California

Miller Children's and Women's Hospital Long Beach, Long Beach, California

Children's Hospital Los Angeles, Los Angeles, California

Cedars Sinai Medical Center, Los Angeles, California

Valley Children's Hospital, Madera, California

UCSF Benioff Children's Hospital Oakland, Oakland, California

Children's Hospital of Orange County, Orange, California

Lucile Packard Children's Hospital Stanford University, Palo Alto, California

Sutter Medical Center Sacramento, Sacramento, California

University of California Davis Comprehensive Cancer Center, Sacramento, California

Rady Children's Hospital - San Diego, San Diego, California

Naval Medical Center -San Diego, San Diego, California

UCSF Medical Center-Parnassus, San Francisco, California

UCSF Medical Center-Mission Bay, San Francisco, California

Children's Hospital Colorado, Aurora, Colorado

Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, Denver, Colorado

Connecticut Children's Medical Center, Hartford, Connecticut

Yale University, New Haven, Connecticut

Alfred I duPont Hospital for Children, Wilmington, Delaware

Children's National Medical Center, Washington, District of Columbia

Golisano Children's Hospital of Southwest Florida, Fort Myers, Florida

University of Florida Health Science Center - Gainesville, Gainesville, Florida

Nemours Children's Clinic-Jacksonville, Jacksonville, Florida

University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida

Nicklaus Children's Hospital, Miami, Florida

AdventHealth Orlando, Orlando, Florida

Arnold Palmer Hospital for Children, Orlando, Florida

Orlando Health Cancer Institute, Orlando, Florida

Nemours Children's Hospital, Orlando, Florida

Nemours Children's Clinic - Pensacola, Pensacola, Florida

Johns Hopkins All Children's Hospital, Saint Petersburg, Florida

Tampa General Hospital, Tampa, Florida

Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa, Florida

Saint Mary's Hospital, West Palm Beach, Florida

Children's Healthcare of Atlanta - Egleston, Atlanta, Georgia

Augusta University Medical Center, Augusta, Georgia

Memorial Health University Medical Center, Savannah, Georgia

University of Hawaii Cancer Center, Honolulu, Hawaii

Kapiolani Medical Center for Women and Children, Honolulu, Hawaii

Saint Luke's Cancer Institute - Boise, Boise, Idaho

Lurie Children's Hospital-Chicago, Chicago, Illinois

University of Illinois, Chicago, Illinois

University of Chicago Comprehensive Cancer Center, Chicago, Illinois

Advocate Children's Hospital-Oak Lawn, Oak Lawn, Illinois

Saint Jude Midwest Affiliate, Peoria, Illinois

Southern Illinois University School of Medicine, Springfield, Illinois

Riley Hospital for Children, Indianapolis, Indiana

Ascension Saint Vincent Indianapolis Hospital, Indianapolis, Indiana

Blank Children's Hospital, Des Moines, Iowa

University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa

University of Kentucky/Markey Cancer Center, Lexington, Kentucky

Norton Children's Hospital, Louisville, Kentucky

Children's Hospital New Orleans, New Orleans, Louisiana

Ochsner Medical Center Jefferson, New Orleans, Louisiana

Maine Children's Cancer Program, Scarborough, Maine

Sinai Hospital of Baltimore, Baltimore, Maryland

Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland

Massachusetts General Hospital Cancer Center, Boston, Massachusetts

Dana-Farber Cancer Institute, Boston, Massachusetts

Wayne State University/Karmanos Cancer Institute, Detroit, Michigan

Ascension Saint John Hospital, Detroit, Michigan

Michigan State University Clinical Center, East Lansing, Michigan

Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, Michigan

Beaumont Children's Hospital-Royal Oak, Royal Oak, Michigan

Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis, Minnesota

University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota

Mayo Clinic in Rochester, Rochester, Minnesota

University of Mississippi Medical Center, Jackson, Mississippi

Columbia Regional, Columbia, Missouri

Children's Mercy Hospitals and Clinics, Kansas City, Missouri

Washington University School of Medicine, Saint Louis, Missouri

Mercy Hospital Saint Louis, Saint Louis, Missouri

Children's Hospital and Medical Center of Omaha, Omaha, Nebraska

University of Nebraska Medical Center, Omaha, Nebraska

University Medical Center of Southern Nevada, Las Vegas, Nevada

Sunrise Hospital and Medical Center, Las Vegas, Nevada

Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas, Nevada

Summerlin Hospital Medical Center, Las Vegas, Nevada

Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon, New Hampshire

Hackensack University Medical Center, Hackensack, New Jersey

Morristown Medical Center, Morristown, New Jersey

Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick, New Jersey

Newark Beth Israel Medical Center, Newark, New Jersey

Saint Joseph's Regional Medical Center, Paterson, New Jersey

University of New Mexico Cancer Center, Albuquerque, New Mexico

Albany Medical Center, Albany, New York

Montefiore Medical Center - Moses Campus, Bronx, New York

Roswell Park Cancer Institute, Buffalo, New York

NYU Winthrop Hospital, Mineola, New York

The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park, New York

Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York

Memorial Sloan Kettering Cancer Center, New York, New York

NYP/Weill Cornell Medical Center, New York, New York

University of Rochester, Rochester, New York

State University of New York Upstate Medical University, Syracuse, New York

New York Medical College, Valhalla, New York

Mission Hospital, Asheville, North Carolina

UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina

Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina

Duke University Medical Center, Durham, North Carolina

Wake Forest University Health Sciences, Winston-Salem, North Carolina

Children's Hospital Medical Center of Akron, Akron, Ohio

Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio

Rainbow Babies and Childrens Hospital, Cleveland, Ohio

Cleveland Clinic Foundation, Cleveland, Ohio

Nationwide Children's Hospital, Columbus, Ohio

Dayton Children's Hospital, Dayton, Ohio

ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo, Ohio

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

Legacy Emanuel Children's Hospital, Portland, Oregon

Oregon Health and Science University, Portland, Oregon

Lehigh Valley Hospital - Muhlenberg, Bethlehem, Pennsylvania

Penn State Children's Hospital, Hershey, Pennsylvania

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

Saint Christopher's Hospital for Children, Philadelphia, Pennsylvania

Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania

Rhode Island Hospital, Providence, Rhode Island

Medical University of South Carolina, Charleston, South Carolina

Prisma Health Richland Hospital, Columbia, South Carolina

BI-LO Charities Children's Cancer Center, Greenville, South Carolina

Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota

T C Thompson Children's Hospital, Chattanooga, Tennessee

East Tennessee Childrens Hospital, Knoxville, Tennessee

Saint Jude Children's Research Hospital, Memphis, Tennessee

The Children's Hospital at TriStar Centennial, Nashville, Tennessee

Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee

Dell Children's Medical Center of Central Texas, Austin, Texas

Driscoll Children's Hospital, Corpus Christi, Texas

Medical City Dallas Hospital, Dallas, Texas

UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas

El Paso Children's Hospital, El Paso, Texas

Cook Children's Medical Center, Fort Worth, Texas

Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas

Children's Hospital of San Antonio, San Antonio, Texas

Methodist Children's Hospital of South Texas, San Antonio, Texas

University of Texas Health Science Center at San Antonio, San Antonio, Texas

Scott and White Memorial Hospital, Temple, Texas

Primary Children's Hospital, Salt Lake City, Utah

Inova Fairfax Hospital, Falls Church, Virginia

Children's Hospital of The King's Daughters, Norfolk, Virginia

Naval Medical Center - Portsmouth, Portsmouth, Virginia

Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia

Seattle Children's Hospital, Seattle, Washington

Providence Sacred Heart Medical Center and Children's Hospital, Spokane, Washington

Mary Bridge Children's Hospital and Health Center, Tacoma, Washington

Madigan Army Medical Center, Tacoma, Washington

University of Wisconsin Carbone Cancer Center, Madison, Wisconsin

Children's Hospital of Wisconsin, Milwaukee, Wisconsin

Conditions: Anaplastic Large Cell Lymphoma, ALK-Positive, Ann Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell Lymphoma, Ann Arbor Stage III Noncutaneous Childhood Anaplastic Large Cell Lymphoma, Ann Arbor Stage IV Noncutaneous Childhood Anaplastic Large Cell Lymphoma

Learn More ›

Browse by State

Dexamethasone treatment options in Alabama

Dexamethasone treatment options in Alaska

Dexamethasone treatment options in Arizona

Dexamethasone treatment options in Arkansas

Dexamethasone treatment options in California

Dexamethasone treatment options in Colorado

Dexamethasone treatment options in Connecticut

Dexamethasone treatment options in Delaware

Dexamethasone treatment options in District of Columbia

Dexamethasone treatment options in Florida

Dexamethasone treatment options in Georgia

Dexamethasone treatment options in Hawaii

Dexamethasone treatment options in Idaho

Dexamethasone treatment options in Illinois

Dexamethasone treatment options in Indiana

Dexamethasone treatment options in Iowa

Dexamethasone treatment options in Kansas

Dexamethasone treatment options in Kentucky

Dexamethasone treatment options in Louisiana

Dexamethasone treatment options in Maine

Dexamethasone treatment options in Montana

Dexamethasone treatment options in Nebraska

Dexamethasone treatment options in Nevada

Dexamethasone treatment options in New Hampshire

Dexamethasone treatment options in New Jersey

Dexamethasone treatment options in New Mexico

Dexamethasone treatment options in New York

Dexamethasone treatment options in North Carolina

Dexamethasone treatment options in North Dakota

Dexamethasone treatment options in Ohio

Dexamethasone treatment options in Oklahoma

Dexamethasone treatment options in Oregon

Dexamethasone treatment options in Maryland

Dexamethasone treatment options in Massachusetts

Dexamethasone treatment options in Michigan

Dexamethasone treatment options in Minnesota

Dexamethasone treatment options in Mississippi

Dexamethasone treatment options in Missouri

Dexamethasone treatment options in Pennsylvania

Dexamethasone treatment options in Rhode Island

Dexamethasone treatment options in South Carolina

Dexamethasone treatment options in South Dakota

Dexamethasone treatment options in Tennessee

Dexamethasone treatment options in Texas

Dexamethasone treatment options in Utah

Dexamethasone treatment options in Vermont

Dexamethasone treatment options in Virginia

Dexamethasone treatment options in Washington

Dexamethasone treatment options in West Virginia

Dexamethasone treatment options in Wisconsin

Dexamethasone treatment options in Wyoming